Tertiapin-Q

(HB1108)

Certificate of Analysis

Latest Certificate of Analysis

Download the latest CoA for this product:

Download CoA

Download Batch-Specific CoA

To download the CoA for a batch, enter the batch ID below:

Technical documents: CoA SDS Datasheet

Product overview

Name Tertiapin-Q
Purity >95%
Description Potent inward rectifier K+ channel blocker
Write Your Own Review
You're reviewing:Tertiapin-Q
Rate this item:

Images

Tertiapin-Q product vial image | Hello Bio

Biological Data

Biological description Potent inward rectifier K+ channel blocker. Inhibits Kir1.1 (ROMK1) and Kir3.1/3.4 (GIRK1/4) (Kd values are 1.3 and 13.3 nM respectively).

Solubility & Handling

Solubility overview Soluble in water (2mg/ml)
Storage instructions -20°C (desiccate)
Storage of solutions Prepare and use solutions on the same day if possible. Store solutions at -20°C for up to one month if storage is required. Equilibrate to RT and ensure the solution is precipitate free before use.
Shipping Conditions Stable for ambient temperature shipping. Follow storage instructions on receipt.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >95%
Chemical name ALC*NC*NRIIIPHQC*WKKC*GKK (Modifications: Disulfide bonds 3 - 14 and 5 - 18, C-terminal amide)
Molecular Weight 2453.06
Chemical structure Tertiapin-Q  [910044-56-3] Chemical Structure
Molecular Formula C106H175N35O24S4
CAS Number 910044-56-3
PubChem identifier 92131436
SMILES CC[C@H](C)[C@H]1C(=O)NC(C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]3CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC3=O)CC4=CNC5=CC=CC=C54)CCCCN)CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N)C(=O)N[C@H](C(=O)N1)CC(=O)N)CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)CCC(=O)N)CC6=CNC=N6)[C@@H](C)CC)[C@@H](C)CC
InChi InChI=1S/C100H163N31O23S4/c1-10-52(6)79-98(152)129-80(53(7)11-2)99(153)130-81(54(8)12-3)100(154)131-37-23-30-74(131)97(151)123-67(40-57-44-110-50-113-57)91(145)118-64(31-32-75(106)132)88(142)125-71-47-157-158-48-72(126-89(143)65(38-51(4)5)119-83(137)55(9)
InChiKey GYOKDEHVCCTTJF-VJPNZKQTSA-N
MDL number MFCD02684419

References for Tertiapin-Q

References are publications that support the biological activity of the product
  • Engineered specific and high-affinity inhibitor for a subtype of inward-rectifier K+ channels.

    Ramu Y et al (2008) Proc Natl Acad Sci U S A 105(31) : 10774-8.
  • The effects of tertiapin-Q on responses of the sinoatrial pacemaker of the guinea-pig heart to vagal nerve stimulation and muscarinic agonists.

    Bolter CP et al (2008) Exp Physiol 93(1) : 53-63.
  • GABAergic activation of an inwardly rectifying K+ current in mouse cerebellar Purkinje cells.

    Tabata T et al (2005) J Physiol 563(Pt 2) : 443-57.
  • Synthesis of a stable form of tertiapin: a high-affinity inhibitor for inward-rectifier K+ channels.

    Jin W et al (1999) Biochemistry 38(43) : 14286-93.

4 Item(s)

Publications
These publications cite the use of Tertiapin-Q purchased from Hello Bio:
  • An Etiological Foxp2 Mutation Impairs Neuronal Gain in Layer VI Cortico-Thalamic Cells through Increased GABAB/GIRK Signaling

    Druart M et al (2020) J Neurosci 40(44) : 8543-8555
    PubMedID: 33020214

1 Item